Dr. Bondi’s laboratory explores therapeutic strategies after experimental TBI, such as pharmacotherapies and environmental enrichment, for complex neurobehavioral deficits and neurochemical alterations relevant to psychiatric disorders and comorbidities. Her team pursues a variety of behavioral, neurochemical, and molecular-based approaches encompassing the overlap of cognitive neuroscience, stress circuitry, and TBI neuropathology.